clinical trial to investigate pharmacokinetic interaction between HGP0904, HGP0608 and HGP1405

A randomized, open-label, 4-way crossover single dose clinical trial to investigate the pharmacokinetic interaction between HGP0904, HGP0608 and HGP1405 when administered alone and in combination in healthy male volunteers

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CRIS

Registry ID

KCT0001693

Enrollment

Registered

2015-11-06

Start date

2014-08-14

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : HGP0904 10mg single oral treatment, HGP0608 100mg single oral treatment, HGP1405 25mg single oral treatment, HGP0904 10mg + HGP0608 100mg + HGP1405 25mg single oral combination treatment, 4way

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Healthy men

Exclusion criteria

Exclusion criteria: Gastrointestinal disease affecting drug absorption

Design outcomes

Primary

Measure	Time frame
AUClast, Cmax	—

Secondary

Measure	Time frame
AUCinf, Tmax, t1/2, CL/F, Vz/F	—

Countries

Korea, Republic of

Contacts

Public ContactAeri Lee

Seoul National University Bundang Hospital

Outcome results